Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis

BACKGROUND: Patients with type 2 diabetes (T2DM) are at risk of long-term vascular complications. In trials, exenatide once weekly (ExQW), a GLP-1R agonist, improved glycemia, weight, blood pressure (BP), and lipids in patients with T2DM. We simulated potential effects of ExQW on vascular complicati...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Gaebler, Julia A, Soto-Campos, Gerardo, Alperin, Peter, Cohen, Marc, Blickensderfer, Amy, Wintle, Matthew, Maggs, David, Hoogwerf, Byron, Han, Jenny, Pencek, Richard, Peskin, Barbara
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Dove Medical Press 2012
विषय:
Original Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3346268/
https://ncbi.nlm.nih.gov/pubmed/22566747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S28744
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन